Showing results (21-30 of 45) with videos related to
Sort By:
Pageof 5
Oncotarget|October 14, 2015
Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinomaIna Kurth, Linda Hein, Katrin Mäbert, et al.Molecular Cancer Research : MCR|July 21, 2021
Establishment of a Plasticity-Associated Risk Model Based on a SOX2- and SOX9-Related Gene Set in Head and Neck Squamous Cell CarcinomaKaram Khorani, Julia Schwaerzler, Sebastian Burkart, et al.Iscience|May 25, 2026
A unified single-cell atlas of HNSCC: Toward characterizing HPV- and sex-associated TME variabilityCristina Conde-Lopez, Divyasree Marripati, Maria Jose Besso, et al.Cancers|April 30, 2021
Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell CarcinomasLina Lüttich, María José Besso, Stephan Heiden, et al.Cancers|March 29, 2023
A Novel Subgroup of UCHL1-Related Cancers Is Associated with Genomic Instability and Sensitivity to DNA-Damaging TreatmentSebastian Burkart, Christopher Weusthof, Karam Khorani, et al.Oncogene|June 3, 2021
Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54LJacqueline Nathansen, Vasyl Lukiyanchuk, Linda Hein, et al.International Journal of Cancer|June 11, 2015
Development of novel radiochemotherapy approaches targeting prostate tumor progenitor cells using nanohybridsArturo Castro Nava, Monica Cojoc, Claudia Peitzsch, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 1, 2024
Transcriptomic and epigenetic landscape of nimorazole-enhanced radiochemotherapy in head and neck cancerMaría José Besso, Verena Bitto, Lydia Koi, et al.Cancers|February 24, 2024
Epigenetic Targeting to Overcome Radioresistance in Head and Neck CancerIñaki Schniewind, Maria José Besso, Sebastian Klicker, et al.Journal of Translational Medicine|August 26, 2023
Prognostic biomarkers for the response to the radiosensitizer nimorazole combined with RCTx: a pre-clinical trial in HNSCC xenograftsLydia Koi, Verena Bitto, Corina Weise, et al.Pageof 5